MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,588,359 | +65159.0% | 1,473,254 | -4.5% | 1.07% | -22.7% |
Q2 2023 | $7,031 | -16.3% | 1,542,743 | -9.7% | 1.39% | -19.2% |
Q1 2023 | $8,405 | -3.9% | 1,708,348 | +3.6% | 1.72% | -8.4% |
Q4 2022 | $8,749 | -99.9% | 1,648,238 | -11.7% | 1.88% | -17.5% |
Q3 2022 | $11,880,000 | +14.0% | 1,867,113 | -17.3% | 2.28% | +23.3% |
Q2 2022 | $10,423,000 | -29.8% | 2,258,500 | +7.5% | 1.85% | -5.3% |
Q1 2022 | $14,849,000 | -39.9% | 2,100,000 | -13.1% | 1.95% | +1.1% |
Q4 2021 | $24,702,000 | -11.7% | 2,415,500 | +4.8% | 1.93% | -11.3% |
Q3 2021 | $27,978,000 | – | 2,305,500 | – | 2.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |